Trial Profile
Intensive Phosphate Control in Development of Renal End Points and Mortality in CKD (the IPeR Study)
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 30 Jun 2014
Price :
$35
*
At a glance
- Drugs Calcium acetate (Primary)
- Indications Renal failure
- Focus Therapeutic Use
- Acronyms IPeR
- 30 Jun 2014 New trial record